Parataxis Capital’s merger with SilverBox Corp IV combines $240M trust capital and $400M equity facility, fueling its BTC treasury strategy and global expansion, including a strategic South Korea pivot.
Parataxis Capital announced a definitive agreement to merge with SilverBox Corp IV via a SPAC transaction, potentially raising $640M. The deal combines $240M trust capital with a $400M equity facility and allocates $31M for initial Bitcoin purchases. Targeting a Q4 2025 closing, the transaction supports the firm’s BTC treasury strategy and international expansion, highlighted by the acquisition of Bridge Biotherapeutics to form Parataxis Korea.